Colombia vs Venezuela, Bolivarian Republic of: Antenatal care attendees positive for syphilis who received treatment
Colombia
90.0%
in 2024
Venezuela, Bolivarian Republic of
90.0%
in 2024
Colombia rank
50th
Venezuela, Bolivarian Republic of rank
50th
Antenatal care attendees positive for syphilis who received treatment over time
- Colombia
- Venezuela, Bolivarian Republic of
How they compare
Colombia currently reports 90.0% against 90.0% in Venezuela, Bolivarian Republic of, a difference of 0.0%.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Colombia ahead.
Colombia ranks 50th and Venezuela, Bolivarian Republic of ranks 50th of 79 countries.
Across the 2 decades both report, Colombia averaged higher in 1 and Venezuela, Bolivarian Republic of in 1.
Head to head by decade
| Decade | Colombia | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.7% | 23.1% | 60.7% | Colombia |
| 2020s | 81.8% | 86.2% | 4.4% | Venezuela, Bolivarian Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antenatal care attendees positive for syphilis who received treatment, Colombia or Venezuela, Bolivarian Republic of?
- Colombia, at 90.0% against 90.0% in Venezuela, Bolivarian Republic of as of 2024.
- What is the difference in antenatal care attendees positive for syphilis who received treatment between Colombia and Venezuela, Bolivarian Republic of?
- 0.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Venezuela, Bolivarian Republic of?
- 5 years are reported by both, from 2017 to 2024.
- How do Colombia and Venezuela, Bolivarian Republic of rank globally for antenatal care attendees positive for syphilis who received treatment?
- Colombia ranks 50th and Venezuela, Bolivarian Republic of ranks 50th of 79 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Antenatal care attendees positive for syphilis who received treatment (%), reported. Statizoid refreshes it automatically from the source and publishes the full history for both places.